Awiqli (insulin icodec)

pCPA File Number: 22715
Negotiation Status:
Active Negotiation
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CDA-AMC Project Number:
SR0790-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable